1. Home
  2. VANI vs HLN Comparison

VANI vs HLN Comparison

Compare VANI & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.17

Market Cap

100.0M

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$8.97

Market Cap

43.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
HLN
Founded
1998
2022
Country
United States
United Kingdom
Employees
36
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
100.0M
43.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
VANI
HLN
Price
$1.17
$8.97
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$3.50
N/A
AVG Volume (30 Days)
294.8K
8.5M
Earning Date
05-14-2026
02-26-2026
Dividend Yield
N/A
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
N/A
$6.55
Revenue Next Year
N/A
$4.42
P/E Ratio
N/A
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$8.71
52 Week High
$1.92
$11.42

Technical Indicators

Market Signals
Indicator
VANI
HLN
Relative Strength Index (RSI) 44.48 34.64
Support Level $1.08 $8.74
Resistance Level $1.55 $10.03
Average True Range (ATR) 0.07 0.15
MACD -0.02 -0.01
Stochastic Oscillator 18.52 10.53

Price Performance

Historical Comparison
VANI
HLN

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: